Spotlight Therapeutics In vivo gene editing Illuminating cures within the genome
Total raised: $66.5M
Investors 4
| Date | Name | Website |
| - | Team Build... | teambuilde... |
| - | Tsingyuan ... | tsingyuan.... |
| - | Foothill V... | foothill.v... |
| - | GV | gv.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.03.2022 | Series B | $36.5M | - |
| 30.11.2020 | Series A | $30M | GV |
Mentions in press and media 4
| Date | Title | Description | Source |
| 22.03.2022 | Spotlight Therapeutics Raises $36.5M in Series B Funding | Spotlight Therapeutics, Inc., a Hayward, California-based biotechnology company applying new insight... | finsmes.co... |
| 22.03.2022 | Spotlight Therapeutics Raises $36.5M Series B | SAN FRANCISCO, CA, Spotlight Therapeutics today announced a $36.5 million Series B financing to fu... | vcnewsdail... |
| 02.12.2020 | Daily funding roundup - Dec. 1st, 2020 | WaveOne has raised $6.5M; Databand landed $14.5M; Proscia has secured $23M Reposite: Reposite is a ... | vator.tv/n... |
| 30.11.2020 | Spotlight Therapeutics Closes $30M Series A Led by GV to Adv... | Spotlight Therapeutics, Inc., a biotechnology company developing non-viral gene editing therapeutics... | marketscre... |